Castle Biosciences, Inc. (CSTL)

NASDAQ: CSTL · Real-Time Price · USD

39.59

+0.18 (0.44%)

At close: Dec 4, 2025, 4:00 PM EST

39.62

0.00 (0.00%)

Pre-market: Dec 5, 2025, 6:03 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Dermatologic	257.00M	Log In	Log In	Log In	Log In	Upgrade
Dermatologic Growth	40.15%	Log In	Log In	Log In	Log In	Upgrade
Non-Dermatologic	75.07M	Log In	Log In	Log In	Log In	Upgrade
Non-Dermatologic Growth	106.17%	Log In	Log In	Log In	Log In	Upgrade
Diagnostic and Prognostic Cancer Test	-	Log In	Log In	Log In	Log In	Upgrade
Diagnostic and Prognostic Cancer Test Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	332.07M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	51.09%	Log In	Log In	Log In	Log In	Upgrade